Specialty Chemicals company Balaji Amines announced Q1FY26 results Revenue from Operations for Q1FY26 stood at Rs 367 crore, as compared to Rs 361 crore in Q4FY25 keeping the performance track intact though the volume growth is seen. The stable commodity prices have allowed us to have the track of performance. Total volumes stood at 27,570 MT for Q1FY26 as against 25,871 MT in Q4FY25. For Q1FY26 Amines volumes stood at 7,573 MT. Amines Derivatives volumes stood at 8,108 MT. Specialty Chemicals volumes stood at 11,889 MT. EBITDA for Q1FY26 was Rs 64 crore, as compared to Rs 68 crore in Q4FY25 and Rs 74 crore in Q1FY25. EBITDA margin for Q1FY26 stood at 17% as against 19% in Q4FY25 and 19% in Q1FY25. PAT for Q1FY26 was Rs 37 crore as compared to Rs 40 crore in Q4FY25. Diluted EPS for Q1FY26 stood at Rs 11.73 per equity share as against Rs 12.36 in Q4FY25. D. Ram Reddy, Managing Director, said: “During Q1FY26, our financial and business performance remained stable, supported by a disciplined working model with stable commodity prices. As volume uptake gradually improves , we anticipate EBITDA and PAT margins to expand, in line with the industry recovery. With the present global and domestic scenario, the utilization of expanded capacities may be impacted in the coming quarters until the basic contribution for our products come through. At BAL, we remain focused on driving sustainable progress, backed by ongoing investments in key projects and our commitment to operational excellence. Electronic Grade DMC, Propylene Glycol Pharma Grade are yet to yield better volumes in serving the domestic market as we have a better product to offer at a competitive pricing, aligning with our strategic growth objectives. These initiatives are designed to strengthen our market presence, enhance product offerings, and meet the evolving needs of our customers. Looking ahead, we maintain a stable outlook for short term opportunities, anticipating growth and increased market driven balanced approach for medium to long term with better prospects. As our inherent strengths and competencies position us as a leading force in Amines and Specialty Chemicals, helping us navigate market dynamics and advance towards greater excellence.” Result PDF